Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignancies VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing… Read More
Transaction to extend Labcorp’s leadership in oncology and expand access to the company’s high-quality clinical laboratory services BURLINGTON, NC & MIAMI, FL – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory… Read More
HEALWELL has signed a $50 million credit agreement, contingent on and in support of its acquisition of Orion Health, with credit to be provided by a syndicate of Schedule I… Read More
RESEARCH TRIANGLE PARK, NC – IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named… Read More
Augurex has received UK Conformity Assessed marking for JOINTstat®, authorizing its use in Great Britain for rheumatoid arthritis diagnosis and management. JOINTstat® is a well-established rheumatoid arthritis blood test in… Read More
